… activated cells of mesenchymal origin in the intestinal wall, is the basis of several … disorders,
in particular inflammatory bowel disease (IBD) (namely Crohn’s disease and ulcerative colitis…

… intestinal microorganisms and the host may provide crucial insight into the pathogenesis
of inflammatory bowel disease as well as new avenues to prevent and treat the disease. …

… colitis is a chronic inflammatory bowel disease of multifactorial origin whose etiology and
pathogenesis … In infants and toddlers with chronic inflammatory bowel disease, the initial work-…

… (UC) are the two main phenotypes of Inflammatory Bowel disease (IBD) and are increasing
in prevalence throughout the world. They are chronic relapsing inflammatory disorders of the …

… Inflammatory bowel disease (IBD), which affects millions of people worldwide, includes
two separate diseases: Crohn’s disease (CD) and ulcerative colitis (UC). Although the …

… Therapeutic targets of novel biologics and small molecules for the treatment of inflammatory
bowel disease. Biologics and small molecules are indicated by red and orange colors, …

… of the risk of serious viral infections in Inflammatory Bowel diseases (IBD) are unclear. …
Most patients with Inflammatory Bowel diseases (IBD) are exposed for prolonged periods to …

… Inflammatory bowel disease cohort identification and inclusion for patients is shown in Figure
1. Based on selection criteria, we identified IBD patients based on at least 2 IBD diagnoses …

… Inflammatory bowel disease (IBD) refers to a group of heterogeneous disorders associated
with chronic inflammation of the gut, having a high rate of incidence in the world. In the …

… Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a
… Dynamics of metatranscription in the inflammatory bowel disease gut microbiome. Nature …